Division of Cardiology/Department of Medicine, University of Jordan, Amman, Jordan.
Division of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Queen Rania Street, Al Jubeiha, Amman, 11942, Jordan.
J Nucl Cardiol. 2020 Oct;27(5):1596-1606. doi: 10.1007/s12350-019-01725-9. Epub 2019 May 1.
The significance of post-stress reduction in left ventricular ejection fraction (LVEF) in patients with normal perfusion on adenosine stress/rest imaging remains controversial.
Consecutive patients who underwent 2-day adenosine gated stress/rest Tc-sestamibi imaging and had normal perfusion were analyzed. LVEF was quantified at rest and 1 hour post-adenosine. Patients were followed up for hard (cardiac death or nonfatal MI) and soft (coronary revascularization or congestive heart failure) cardiac events for 24.1 ± 11.0 months.
Of 560 patients included in the study, 135 (24.1%) had a post-stress reduction in LVEF of ≥ 5%. Rest LVEF (P < 0.001), known history of CAD (P = 0.01) and transient ischemic dilatation ratio (P = 0.02) were independent predictors of LVEF reduction. Event-free survivals were similar in patients with and without ≥ 5% LVEF reduction (P = 0.8). The unadjusted hazard ratio (95% CI) for cardiac events for ≥ 5% LVEF reduction was 1.09 (0.55-2.15), P = 0.81, while the hazard ratio adjusted for known history of CAD, smoking, post-stress LVEF and peak heart rate was 0.87 (0.44-1.75), P = 0.71.
Significant post-adenosine reduction in LVEF occurs in about one-fourth of patients with normal perfusion but does not confer adverse prognosis compared with patients without such reduction.
腺苷负荷/静息门控心肌灌注显像提示心肌灌注正常的患者,其应激后左心室射血分数(LVEF)降低的意义仍存在争议。
对连续行 2 天腺苷门控应激/静息 Tc- sestamibi 显像且心肌灌注正常的患者进行分析。静息和腺苷后 1 小时分别定量 LVEF。对患者进行 24.1±11.0 个月的硬终点(心脏死亡或非致死性心肌梗死)和软终点(冠状动脉血运重建或充血性心力衰竭)随访。
在纳入的 560 例患者中,135 例(24.1%)应激后 LVEF 降低≥5%。静息 LVEF(P<0.001)、已知 CAD 病史(P=0.01)和短暂性缺血扩张比(P=0.02)是 LVEF 降低的独立预测因子。LVEF 降低≥5%的患者和 LVEF 无降低的患者之间,无事件生存情况相似(P=0.8)。LVEF 降低≥5%的患者校正已知 CAD 病史、吸烟、应激后 LVEF 和峰值心率后的心脏事件发生的风险比(95%CI)为 1.09(0.55-2.15),P=0.81,而调整后的风险比为 0.87(0.44-1.75),P=0.71。
约四分之一的心肌灌注正常的患者存在显著的腺苷后 LVEF 降低,但与 LVEF 无降低的患者相比,该变化并未导致不良预后。